glucagon has been researched along with devazepide in 7 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (devazepide) | Trials (devazepide) | Recent Studies (post-2010) (devazepide) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 780 | 5 | 42 |
Protein | Taxonomy | glucagon (IC50) | devazepide (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.0009 | |
Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
Cholecystokinin receptor type A | Homo sapiens (human) | 0.0002 | |
Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.245 | |
Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.27 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahrén, B; Karlsson, S | 2 |
Beccaria, L; Coker, LD; Gertz, BJ; Gettys, TW; Kanayama, S; Liddle, RA; Rushakoff, RJ; Taylor, IL; Williams, VC | 1 |
Rossetti, L; Shulman, GI; Zawalich, WS | 1 |
Ahrén, B; Gingerich, RL; Havel, PJ | 1 |
Burton, FR; Garvin, PJ; Niehoff, ML; Presti, ME; Solomon, H | 1 |
Chisholm, C; Fung, LC; Greenberg, GR | 1 |
1 trial(s) available for glucagon and devazepide
Article | Year |
---|---|
Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
Topics: Administration, Oral; Adult; Benzodiazepinones; Blood Glucose; Cholecystokinin; Devazepide; Eating; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Pancreatic Polypeptide; Receptors, Cholecystokinin | 1990 |
6 other study(ies) available for glucagon and devazepide
Article | Year |
---|---|
Peptide receptor antagonists in the study of insulin and glucagon secretion in mice.
Topics: Animals; Benzodiazepinones; Blood Glucose; Cholecystokinin; Deoxyglucose; Devazepide; Female; Gastrin-Releasing Peptide; Glucagon; Insulin; Insulin Secretion; Mice; Peptides; Receptors, Cell Surface; Vasoactive Intestinal Peptide | 1990 |
Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
Topics: Animals; Benzodiazepinones; Blood Glucose; Devazepide; Female; Glucagon; Glutamine; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred Strains; Proglumide; Receptors, Cholecystokinin | 1989 |
Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding.
Topics: Animals; Benzodiazepinones; Blood Glucose; Caseins; Cholecystokinin; Devazepide; Food; Glucagon; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Male; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Tyrosine | 1987 |
Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice.
Topics: Animals; Benzodiazepinones; Blood Glucose; Devazepide; Female; Glucagon; Glucagon-Like Peptide 1; Hormone Antagonists; Insulin; Mice; Mice, Inbred Strains; Neurotransmitter Agents; Pancreatic Polypeptide; Peptide Fragments; Protein Precursors; Receptors, Cholecystokinin; Sincalide | 1995 |
Effect of L-364,718 on pancreatic endocrine function following partial pancreatectomy.
Topics: Animals; Benzodiazepinones; Blood Glucose; Cell Count; Devazepide; Dogs; Female; Glucagon; Glucose; Hormone Antagonists; Insulin; Islets of Langerhans; Pancreas; Pancreatectomy; Receptor, Cholecystokinin A; Receptors, Cholecystokinin | 1996 |
Glucagon-like peptide-1-(7-36) amide and peptide YY mediate intraduodenal fat-induced inhibition of acid secretion in dogs.
Topics: Animals; Benzodiazepinones; Devazepide; Dogs; Duodenum; Fats; Gastric Acid; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Peptide Fragments; Peptide YY; Protein Precursors | 1998 |